Daily market recaps with key events, stock movements, and global influences 4 posts • GPT (4.1 mini) Updated Jun 9, 2025, 12:59 PM FLGTMYGNBNRPRPOIVFPGNYNewGenIvf Group Limited Class A ordinary shares A Danish sperm donor unknowingly carrying a gene mutation that increases cancer risk has fathered at least 67 children, with ten of them currently diagnosed with various types of cancer. The number of affected children could rise as more cases are identified.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Spanish Study
Telomir-1 Age-Reversal, Werner Syndrome Trial Positive; NAD Boost Restores CAR-T Cells, Bioshield Activates NK Cells, Y Chromosome Loss Impairs T Cells | DeepNewz Bio
Daily market recaps with key events, stock movements, and global influences 5 posts • GPT (4.1 mini) Published Jun 8, 2025, 03:03 AM Recent advancements in biotechnology and immunotherapy highlight promising developments in the treatment of rare genetic diseases and cancer. Telomir-1 has demonstrated systemic age-reversal effects in a model of a rare disease, while trials for Werner syndrome, a rare genetic disorder, have reported encouraging results.
University of Arizona Finds Y Chromosome Loss Spreads Between Cells, Worsening Cancer Outcomes and Guiding Male Therapies
Daily market recaps with key events, stock movements, and global influences 4 posts • GPT (4.1 mini) Published Jun 7, 2025, 10:42 AM A recent study published in Nature has found that the loss of the Y chromosome in tumor cells is associated with poorer outcomes in men with cancer. The research indicates that this chromosomal loss not only makes cancer cells more aggressive but may also spread between cells, complicating treatment.
Daily market recaps with key events, stock movements, and global influences 23 posts • GPT (4.1 mini) Updated Jun 7, 2025, 12:45 AM Australian researchers have developed a novel mRNA-based therapy that can expose dormant HIV reservoirs hidden within human immune cells, a breakthrough that may advance efforts toward a functional cure for HIV.
Baby With CPSI Deficiency Released After 307 Days at CHOP Following First Personalized CRISPR Therapy
14 posts • GPT (4.1) Updated Jun 6, 2025, 10:38 PM KJ Muldoon, a nine-month-old infant diagnosed with carbamoyl phosphate synthetase I (CPSI) deficiency, has become the first patient to receive and benefit from a personalized CRISPR gene editing therapy.
Danish Sperm Donor With Lynch Syndrome Mutation Fathers 52 Children in Belgium, 10 Cancer Cases, and Sparks Leiderdorp Clinic Scandal
Daily market recaps with key events, stock movements, and global influences 11 posts • GPT (4.1 mini) Updated Jun 6, 2025, 04:37 PM FLGTMYGNBNRPRPOIVFPGNYNewGenIvf Group Limited Class A ordinary shares A Danish sperm donor carrying a rare genetic mutation linked to Lynch syndrome, which significantly increases the risk of multiple cancer types, has fathered at least 52 children in Belgium and several others in the Netherlands and Israel.
Sperm Donor Genetic Mutations Linked to Cancer in Belgium, Israel, and Eight European Countries
12 posts • GPT (4.1) Updated Jun 5, 2025, 03:50 PM FLGTMYGNBNRPRPOIVFPGNYNewGenIvf Group Limited Class A ordinary shares Health authorities in several countries have reported cases where sperm donors carrying rare cancer-linked genetic mutations have fathered dozens of children across Europe and Israel. In Belgium, a Danish sperm donor with a cancer-causing genetic mutation was found to have fathered at least 53 children, with 51 surviving births, through treatments at 12 fertility clinics.
Australian Scientists Use mRNA Therapy to Expose Dormant HIV Reservoirs, Advancing Potential Functional Cure with WHO Support
5 posts • GPT (4.1 mini) Published Jun 5, 2025, 12:20 PM Australian scientists have developed a novel mRNA-based therapy that successfully exposes dormant HIV hidden within white blood cells. This breakthrough enables the virus reservoirs, which have long evaded detection, to become visible, representing a crucial step toward a potential functional cure for HIV. The method involves delivering mRNA directly to infected cells, allowing researchers to identify and target the elusive virus reservoirs.
Baby KJ With CPS1 Metabolic Disease Discharged After 307 Days Following Pioneering CRISPR Therapy at CHOP by Ahrens-Nicklas, Musunuru, Kassim
Daily market recaps with key events, stock movements, and global influences 15 posts • GPT (4.1 mini) Updated Jun 5, 2025, 12:20 PM KJ Muldoon, a 10-month-old infant diagnosed with a rare metabolic disorder called CPS1 deficiency, has been discharged from the Children's Hospital of Philadelphia (CHOP) after nearly a year of treatment.
Belgian Sperm Donor With Cancer-Linked Gene Fathers Over 50 Children; 10 Have Cancer, Fraud Probe Launched, Israel Reports Similar Case
Daily market recaps with key events, stock movements, and global influences 6 posts • GPT (4.1 mini) Updated Jun 5, 2025, 09:47 AM FLGTMYGNBNRPRPOIVFPGNYNewGenIvf Group Limited Class A ordinary shares Authorities in Belgium have uncovered a sperm donor who carried a rare genetic mutation linked to an increased risk of various cancers in his offspring. The donor fathered between 51 and 67 children, with reports indicating that at least 10 of them have developed cancer.
Johnson & Johnson’s Trispecific Antibody Shows Potential Cure for Multiple Myeloma in 97-Patient Trial
Daily market recaps with key events, stock movements, and global influences 6 posts • GPT (4.1 mini) Published Jun 4, 2025, 05:41 PM Johnson & Johnson's trispecific antibody treatment has demonstrated promising early results in clinical trials for heavily pretreated multiple myeloma patients, a cancer traditionally considered incurable with a median survival of about one year.
Maternal Iron Deficiency Induces Male-to-Female Sex Reversal via SRY Gene; Y Chromosome Loss Affects T Cells and Cancer Mortality in Men
7 posts • GPT (4.1 mini) Published Jun 4, 2025, 05:39 PM Recent scientific studies have revealed that maternal iron deficiency during pregnancy can cause male mouse embryos to develop female reproductive organs, effectively inducing male-to-female sex reversal regardless of genetic sex. This phenomenon is linked to the disruption of the SRY gene, which is critical for male sex determination.
10-Month-Old Baby With CPS1 Deficiency Leaves CHOP After 307 Days Following Personalized CRISPR Gene-Editing Breakthrough
Daily market recaps with key events, stock movements, and global influences 9 posts • GPT (4.1 mini) Updated Jun 4, 2025, 04:49 PM KJ Muldoon, a 10-month-old infant diagnosed with a rare metabolic disorder called CPS1 deficiency, has been discharged from the Children's Hospital of Philadelphia (CHOP) after spending 307 days receiving a pioneering personalized in vivo CRISPR gene-editing therapy.
Belgian Sperm Donor With Cancer-Causing Gene Fathers 67 Children, 52 With Mutation, 10 Diagnosed With Cancer
Daily market recaps with key events, stock movements, and global influences 5 posts • GPT (4.1 mini) Published Jun 3, 2025, 05:20 PM FLGTMYGNBNRPRPOIVFPGNYNewGenIvf Group Limited Class A ordinary shares Belgian authorities have condemned what they describe as negligence in a case involving a sperm donor who carried a cancer-causing genetic mutation and fathered at least 67 children.
Personalized Gene-Editing Treatment Using Gene Replacement Marks Medical First Amid Pharma Industry Acquisition
Daily market recaps with key events, stock movements, and global influences 4 posts • GPT (4.1 mini) Updated Jun 1, 2025, 03:42 AM CRISPRNTLACRBUEDITTSHAVYGR A groundbreaking personalized gene-editing treatment has been successfully administered to an infant, marking a medical first and potentially inaugurating a new subspecialty in medicine.
U.S. Infant Receives First Customized CRISPR Therapy as Gene Replacement Advances and Plasma Exchange Cuts Biological Age
6 posts • GPT (4.1 mini) Updated May 31, 2025, 12:07 PM CRISPRNTLACRBUEDITTSHAVYGR A U.S. infant has become the first person to receive a customized CRISPR therapy designed to target a unique genetic mutation, marking a milestone in precision medicine where treatments are tailored to individual DNA profiles.
Danish Sperm Donor With TP53 Mutation Fathers 67 Children in Eight Countries; 10 Diagnosed With Cancer, 52 in Belgium
Daily market recaps with key events, stock movements, and global influences 15 posts • GPT (4.1) Updated May 30, 2025, 08:40 PM A Danish sperm donor carrying a rare TP53 gene mutation, associated with Li-Fraumeni syndrome and a heightened risk of cancer, fathered at least 67 children across 46 families in eight European countries—Belgium, Denmark, France, Germany, Greece, Spain, Sweden, and the United Kingdom—between 2008 and 2015. The mutation was unknown at the time of donation.
Urgent Stem Cell Donor Appeals for Reece Khan and DJ Daniel Amid Cancer Relapses in UK
Daily market recaps with key events, stock movements, and global influences 11 posts • GPT (4.1) Published May 30, 2025, 05:28 PM Reece Khan, a 16-year-old from Lincoln, has experienced a relapse of acute lymphoblastic leukaemia, a rare cancer affecting the blood and bone marrow, after being cancer-free for 18 months. The diagnosis was delivered on his 16th birthday, and the cancer has now spread to his brain. Reece also has type 1 diabetes, which complicates his treatment.
52 Belgian Children Conceived From Danish Donor With Cancer Gene; Minister Vandenbroucke Orders Audit, No Use in Netherlands
Daily market recaps with key events, stock movements, and global influences 5 posts • GPT (4.1 mini) Published May 30, 2025, 04:57 PM In Belgium, 52 children have been conceived using sperm from a Danish donor carrying a cancer-causing gene. The donor's genetic defect poses a potentially fatal risk. The Belgian government was aware of the issue as early as 2023, prompting Minister Frank Vandenbroucke to order an audit into the matter.
Thousands Celebrate Istanbul Child Ali Declared Cancer-Free After Two Years of Treatment
4 posts • GPT (4.1 mini) Updated May 30, 2025, 03:10 AM Thousands of residents in Istanbul gathered to celebrate the recovery of three-year-old Ali, who was declared cancer-free after undergoing two years of treatment for leukemia. The community released balloons in a public event to mark Ali's successful battle against the disease. More breaking stories on DeepNewz — updated live.
FDA Halts Rocket Pharma’s Phase II RP-A501 Danon Disease Gene Therapy Trial After Patient Death
Daily market recaps with key events, stock movements, and global influences 28May: What does @RocketPharma suspect may have led to the death of a patient dosed with its Danon disease gene therapy candidate RP-A501 in a pivotal trial? And how did three analysts respond to the news?
Verve and VitaRNA Advance Genetic Therapies Amid Intellia Filing and 69% Cholesterol Reduction Breakthrough
5 posts ⢠GPT (4.1 mini) Published May 29, 2025, 07:01 PM Recent developments in genetic therapy highlight the emergence of systemic treatments as a promising approach for addressing inherited conditions and age-related genetic mutations. Verve Therapeutics has been noted for its potential one-time DNA editing therapy aimed at inherited high cholesterol, which could replace lifelong treatments like statins and PCSK9 inhibitors.
U.S. Infant Receives First Personalized CRISPR Therapy for Rare Mutation Using AI-Guided Vectors and NovaIscB Enzyme
Daily market recaps with key events, stock movements, and global influences 22 posts • GPT (4.1 mini) Published May 29, 2025, 04:52 PM CRISPRNTLACRBUEDITTSHAVYGR A U.S. infant has become the first patient to receive a personalized CRISPR gene-editing therapy targeting a rare genetic mutation, marking a milestone in precision medicine. This breakthrough treatment, delivered shortly after birth, demonstrates the potential for customized gene therapies to address a wide range of genetic diseases.
European Sperm Donor With p53 Mutation Linked to Li-Fraumeni Syndrome Fathers 67 Children Across 8 Countries, 10 Diagnosed With Cancer
Daily market recaps with key events, stock movements, and global influences 13 posts • GPT (4.1 mini) Updated May 29, 2025, 02:58 PM A European sperm donor carrying a rare genetic mutation linked to cancer has fathered at least 67 children across eight countries between 2008 and 2015. The donor was found to have a p53 mutation associated with Li-Fraumeni syndrome, a hereditary condition that increases cancer risk.
European Sperm Donor’s Mutation Linked to Cancer in 10 of 67 Children Across Eight Countries
Daily market recaps with key events, stock movements, and global influences 13 posts • GPT (4.1 mini) Updated May 28, 2025, 06:36 PM A sperm donor in Europe, unknowingly carrying a rare genetic mutation linked to cancer, has fathered at least 67 children across eight countries. Among these children, 23 have inherited the mutation, and 10 have been diagnosed with various cancers, including leukemia and non-Hodgkin lymphoma. The sperm donations were made between 2008 and 2015.
UPenn, CHOP Use Custom CRISPR Base Editing to Treat KJ Muldoon's CPS1 Deficiency
Daily market recaps with key events, stock movements, and global influences 10 posts • GPT (4.1) Updated May 28, 2025, 04:27 AM Scientists and doctors at the University of Pennsylvania and the Children's Hospital of Philadelphia have treated KJ Muldoon, a 10-month-old boy, for carbamoyl phosphate synthetase 1 (CPS1) deficiency, a rare genetic disorder causing toxic ammonia buildup.
Melbourne Team Unveils 1ml Blood Test Diagnosing 50% of Rare Genetic Diseases in Children
Daily market recaps with key events, stock movements, and global influences 15 posts • GPT (4.1) Published May 27, 2025, 06:06 PM Researchers at the University of Melbourne have developed a new blood-based proteomic test capable of rapidly diagnosing thousands of rare genetic diseases in infants and children. The test, unveiled at the European Society of Human Genetics conference by Daniella Hock, requires only 1 ml of blood and delivers results in less than three days.
FDA Halts Rocket Pharma Danon Gene Therapy Trial After Patient Death; Shares Drop 63% on May 23
22 posts • GPT (4.1) Updated May 27, 2025, 04:24 PM The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Rocket Pharmaceuticals' Phase 2 gene therapy trial of RP-A501 for Danon disease following the death of a patient. The patient experienced capillary leak syndrome after receiving a high-dose AAV9 vector (6.7×10¹³ GC/kg) and a novel immune suppression agent, identified as a C3 inhibitor.
Thousands in Istanbul’s Sancaktepe Celebrate 3-Year-Old Ali Asaf Demir’s Leukemia Recovery After Two Years of Treatment
Daily market recaps with key events, stock movements, and global influences 20 posts • GPT (4.1 mini) Updated May 27, 2025, 03:36 PM Thousands of people gathered in Istanbul's Sancaktepe district to celebrate the recovery of three-year-old Ali Asaf Demir, who overcame leukemia after being diagnosed at eight months old. Ali Asaf underwent two years of treatment before being declared cancer-free.
New Blood Test Detects 50% of Rare Genetic Diseases, Replaces Invasive Exams; Ambry Genetics Stock Rises 4.4%
Daily market recaps with key events, stock movements, and global influences 7 posts • GPT (4.1 mini) Published May 27, 2025, 01:56 PM A new blood test has been developed that can rapidly detect thousands of rare genetic diseases, identifying pathogenic mutations in up to 50% of cases within a few days.
Danish Sperm Donor Passes TP53 Mutation to 23 Children, 10 Develop Cancer Across 8 European Countries Since 2008
Daily market recaps with key events, stock movements, and global influences 18 posts • GPT (4.1 mini) Updated May 27, 2025, 12:29 PM A Danish sperm donor has been linked to at least 67 births across eight European countries between 2008 and 2015. Genetic testing revealed that the donor carried a rare mutation in the TP53 gene, which is associated with an increased predisposition to early-onset cancers.
Rocket Pharmaceuticals Pauses Phase 2 RP-A501 Trial for Danon Disease After FDA Clinical Hold Following Patient Death
6 posts • GPT (4.1 mini) Published May 27, 2025, 11:18 AM Rocket Pharmaceuticals announced a clinical hold on its Phase 2 pivotal trial of RP-A501, a gene therapy candidate for Danon disease, following the death of a patient. The patient experienced a serious adverse event related to capillary leak syndrome and subsequently passed away due to an acute systemic infection. The U.S. Food and Drug Administration (FDA) imposed the clinical hold to allow for further evaluation of the trial's safety.
Infant KJ Muldoon Receives First Custom Base Editing Therapy for CPS1 Deficiency at University of Pennsylvania
Daily market recaps with key events, stock movements, and global influences 11 posts • GPT (4.1) Published May 27, 2025, 10:31 AM A nine-month-old boy, KJ Muldoon, became the first known patient to receive a custom gene-editing treatment using base editing, a precise form of CRISPR-Cas9 technology. The treatment targeted CPS1 deficiency, a rare genetic disorder causing toxic ammonia buildup in the blood.
Gene Editing Advances Enable 69-Edit Pig Kidney Transplant for 62-Year-Old and Treat Rare Disease in 9-Month-Old Infant
Daily market recaps with key events, stock movements, and global influences 10 posts • GPT (4.1 mini) Published May 27, 2025, 09:44 AM A recent breakthrough in gene editing and organ transplantation has marked a milestone in medical science. A 62-year-old dialysis patient received a pig kidney that had undergone 69 genetic edits to make it compatible with humans, allowing him to immediately stop dialysis.
Danish Sperm Donor With Cancer-Causing Mutation Fathers 67 Children in Europe, 10 Diagnosed With Early-Onset Cancer
Daily market recaps with key events, stock movements, and global influences 20 posts • GPT (4.1 mini) Updated May 26, 2025, 05:35 PM A sperm donor with a rare cancer-causing genetic mutation has fathered at least 67 children across Europe, according to multiple reports. Among these children, 10 have been diagnosed with early-onset cancer. The donor, reportedly of Danish origin, was unaware of carrying the mutation at the time of donation.
Danish Sperm Donor's TP53 Mutation Linked to 10 Childhood Cancer Cases in 67 Children Across Eight European Countries
26 posts • GPT (4.1) Updated May 25, 2025, 05:37 PM A Danish sperm donor carrying a rare mutation in the TP53 gene, associated with Li-Fraumeni syndrome, has fathered at least 67 children across Europe between 2008 and 2015. Of these, 23 children have inherited the mutation, and 10 have been diagnosed with cancer, including leukemia and lymphoma. The case was uncovered after two families contacted fertility clinics when their children developed early-onset cancers.
Daily market recaps with key events, stock movements, and global influences 8 posts • GPT (4.1 mini) Published May 25, 2025, 04:54 AM Chase Miller, a 15-year-old from Ohio, is currently battling a brain tumor and undergoing immunotherapy treatments. Despite the challenges, including a previous surgery that was unable to remove all of the cancer, Chase is looking forward to a Make-A-Wish Foundation-organized trip to San Diego scheduled for June.
Sperm Donor With Rare TP53 Mutation Fathers 67 Children in Eight Countries, 10 Diagnosed With Cancer (2008-2015)
18 posts • GPT (4.1) Published May 24, 2025, 08:21 PM A sperm donor carrying a rare mutation in the TP53 gene, associated with Li-Fraumeni syndrome, fathered at least 67 children from 46 families across eight European countries between 2008 and 2015. Of these children, 23 have been found to carry the mutation, and at least 10 have developed cancers including leukemia and non-Hodgkin lymphoma.
Brazil's SUS Administers R$7 Million Zolgensma for SMA; Spain Funds First Genetic ALS Treatment; New MS Drug Trial
Daily market recaps with key events, stock movements, and global influences MOST EXPENSIVE MEDICINE IN THE WORLD | SUS performs the third infusion of zolgensma in a baby with SMA in São Paulo. With the procedure performed at the Unicamp Hospital, SUS expands access to the world's most expensive gene therapy, which costs around R$ 7 million per dose.
24 posts • GPT (4.1 mini) Published May 24, 2025, 05:17 AM Researchers have introduced MMaDA, a novel class of multimodal diffusion foundation models developed by ByteDance, designed to excel in textual reasoning, multimodal understanding, and text-to-image generation. MMaDA surpasses existing models such as LLaMA-3-7B, Qwen2-7B, SDXL, and Janus by employing a unified diffusion architecture with a shared probabilistic formulation and mixed long chain-of-thought fine-tuning.
Infant KJ With CPS1 Deficiency Receives First Personalized CRISPR Therapy; Chinese Team Cures Thalassemia
Daily market recaps with key events, stock movements, and global influences 29 posts • GPT (4.1) Updated May 23, 2025, 08:13 PM A nine-month-old infant known as KJ, born with a life-threatening genetic disorder caused by a deficiency in the CPS1 liver enzyme, has become the first person to receive a personalized CRISPR gene-editing therapy tailored to his unique genetic mutation.
NIH Uses CRISPR-Associated Transposase for First Personalized Gene Therapy; Stanford Advances RNA Localization; Expert Urges Caution
Daily market recaps with key events, stock movements, and global influences 16 posts • GPT (4.1 mini) Updated May 23, 2025, 04:50 PM Researchers have achieved a milestone in gene editing by successfully delivering the world’s first personalized CRISPR gene therapy to a baby named KJ, who was born with a life-threatening genetic condition.
Young Woman with Aggressive ELA-FUS ALS Shows Unprecedented Recovery After Experimental Treatment
👏 A young woman with an aggressive form of ALS is walking again thanks to an experimental treatment https://t.co/W78Bj4P498 ➡ ELA-FUS is a particularly aggressive form of the disease, which appears very early and progresses rapidly A young woman with ALS is walking again after an experimental treatment that shows an “unprecedented” recovery https://t.co/Uk5ES4uc7R A young woman with ALS walks unaided again after an experimental treatment that shows an “unprecedented” recovery...
First Use of Personalized CRISPR Therapy Saves Baby with CPS1 Deficiency, Treats Immune Disorder
25 posts • Grok (2) Updated May 21, 2025, 08:33 PM In a significant medical advancement, a baby boy named KJ, diagnosed with severe CPS1 deficiency, has become the first person to receive a personalized CRISPR gene-editing therapy. Administered in February 2025 when KJ was 6 months old, the treatment corrected a mutation specific to him, allowing the infant to increase his protein intake and reduce his dependency on other medications to manage ammonia build-up.
Infant Treated for CPS1 Deficiency with World's First Personalized CRISPR Therapy at Children's Hospital of Philadelphia and University of Pennsylvania | DeepNewz Bio
Daily market recaps with key events, stock movements, and global influences 33 posts • Grok (2) Updated May 20, 2025, 08:11 PM An infant named KJ, born with a severe genetic condition known as carbamoyl phosphate synthetase 1 (CPS1) deficiency, has become the first patient to receive a personalized gene-editing treatment using CRISPR technology.
Koh-Lanta Contestant Teheiura Reveals Son Vaitoanui’s Rare Genetic Disorder GNB1 Syndrome, Unable to Speak or Walk
Daily market recaps with key events, stock movements, and global influences 4 posts • GPT (4.1 mini) Published May 19, 2025, 09:08 PM Teheiura, a well-known contestant from the French reality show Koh-Lanta, has publicly discussed for the first time the rare genetic disorder affecting his son, Vaitoanui. The child suffers from GNB1 syndrome, a condition that has left him unable to speak or walk.
Mass General Brigham and Boston Study Finds Widely Prescribed Drug May Offer Hope for Glioblastoma; Links Childhood Brain Cancer to Prenatal Mutations | DeepNewz Bio
5 posts • GPT (4.1 mini) Published May 19, 2025, 09:07 PM A recent study conducted by Mass General Brigham and Boston researchers has identified a widely prescribed medication that may offer new hope for patients with glioblastoma, the most common and aggressive malignant brain tumor in adults. This research provides a promising development in the treatment of glioblastoma, which has historically had limited therapeutic options and poor prognosis.
Newborn with CPS1 Deficiency Treated with World's First Personalized CRISPR Therapy at 97% Precision
Daily market recaps with key events, stock movements, and global influences 50 posts • Grok (2) Published May 19, 2025, 08:15 PM A newborn diagnosed with a rare genetic disorder, carbamoyl-phosphate synthetase 1 (CPS1) deficiency, has been successfully treated with the world's first personalized gene-editing therapy using CRISPR-Cas9 technology.
KJ Muldoon Receives World's First Personalized CRISPR Therapy for CPS1 Deficiency
40 posts • Grok (2) Updated May 19, 2025, 04:08 PM A US infant, KJ Muldoon, aged 9 months, has become the first person to receive a personalized CRISPR gene-editing therapy for a rare genetic liver condition known as CPS1 deficiency. The treatment, developed by researchers Kiran Musunuru and Rebecca Ahrens-Nicklas at the Children's Hospital of Philadelphia, was tailored to correct a specific mutation in KJ's DNA, offering hope for others with similar rare diseases.
Brazil’s SUS Starts Free Zolgensma Gene Therapy for 137 Children with AME; Applications in Recife and Brasília; Anvisa Approves Friedreich’s Ataxia Drug | DeepNewz Brazil
Daily market recaps with key events, stock movements, and global influences 10 posts • GPT (4.1 mini) Published May 18, 2025, 12:22 AM The Brazilian public health system (SUS) has begun administering Zolgensma, a gene therapy treatment for spinal muscular atrophy (AME) type 1, marking a historic milestone as the first gene therapy incorporated into SUS.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Spanish
Contact Spanish, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack